Sec. 20-614. (Formerly Sec. 20-184b). Prescriptions: Form and content. Electronic data intermediaries.
Sec. 20-614. (Formerly Sec. 20-184b). Prescriptions: Form and content. Electronic data intermediaries. (a) A prescription shall be transmitted in either an oral,
written or electronic manner to a pharmacy.
(b) Whenever a pharmacy, or an institutional pharmacy in a hospital dispensing a
drug or device for outpatient use or dispensing a drug or device that is prescribed for
an employee of the hospital or for the employee's spouse or dependent children, receives
an oral or electronically-transmitted prescription, except for a controlled drug, as defined
in section 21a-240, the pharmacist or pharmacy intern shall, not later than the end of
the business day when the prescription was received, record the prescription on a prescription form or computerized printed record including: (1) The name and address of
the prescribing practitioner; (2) the date of the prescription; (3) the name, dosage form,
strength, where applicable, and the amount of the drug prescribed; (4) the name and
address of the patient or, for veterinary prescriptions, the name and address of the owner
and the species of the animal; (5) the directions for use; (6) any required cautionary
statements; and (7) the number of times the prescription may be refilled, including the
use of refill terms "PRN" and "ad lib" in lieu of a specific number of authorized refills.
(c) A written prescription shall bear: (1) The written signature of the prescribing
practitioner or shall comply with the requirements of section 19a-509c; (2) the address
of the practitioner; (3) the date of the prescription; (4) the name, dosage form, strength,
where applicable, and amount of the drug prescribed; (5) the name and address of the
patient or, for veterinary prescriptions, the name and address of the owner and the species
of the animal; (6) the directions for use; (7) any required cautionary statements; and (8)
the number of times the prescription may be refilled, including the use of refill terms
"PRN" and "ad lib" in lieu of a specific number of authorized refills. No written prescription form for a schedule II substance may contain an order for any other legend drug or
device.
(d) (1) As used in this subsection, "electronic data intermediary" means an entity
that provides the infrastructure that connects the computer systems or other electronic
devices utilized by prescribing practitioners with those used by pharmacies in order to
facilitate the secure transmission of electronic prescription orders, refill authorization
requests, communications and other patient care information between such entities.
(2) An electronic data intermediary may transfer electronically transmitted data
between a prescribing practitioner licensed and authorized to prescribe and a pharmacy
of the patient's choice, licensed pursuant to this chapter or licensed under the laws of
any other state or territory of the United States. Electronic data intermediaries shall
not alter the transmitted data except as necessary for technical processing purposes.
Electronic data intermediaries may archive copies of only that electronic data related
to such transmissions necessary to provide for proper auditing and security of such
transmissions. Such data shall only be maintained for the period necessary for auditing
purposes. Electronic data intermediaries shall maintain patient privacy and confidentiality of all archived information as required by state and federal law.
(3) No electronic data intermediary shall operate without the approval of the Commissioner of Consumer Protection. An electronic data intermediary seeking approval
shall apply to the Commission of Pharmacy in the manner prescribed by the commissioner. The commissioner, with the advice and assistance of the commission, shall adopt
regulations, in accordance with the provisions of chapter 54, to establish criteria for the
approval of electronic data intermediaries, to ensure that (A) procedures to be used for
the transmission and retention of prescription data by an intermediary, and (B) mechanisms to be used by an intermediary to safeguard the confidentiality of such data, are
consistent with the provisions and purposes of this section.
(1969, P.A. 48, S. 2; P.A. 75-20; P.A. 77-165, S. 2; P.A. 82-419, S. 43, 47; P.A. 87-589, S. 62, 87; P.A. 95-264, S. 36;
P.A. 99-175, S. 36; P.A. 04-107, S. 1; P.A. 05-272, S. 41.)
History: P.A. 75-20 deleted requirement that prescriptions, whether oral and then recorded or written, contain narcotic
registry number, if applicable, deleted exception for controlled drugs in requirements for written prescriptions and substituted "species" for "breed"; P.A. 77-165 limited to one the number of prescriptions allowed per blank; P.A. 82-419 amended
section to allow more than one prescription on a blank except in case of schedule II substance where previously prohibition
against multiple prescriptions on a blank was absolute; P.A. 87-589 added "including the use of refill terms "PRN" and
"ad lib" in lieu of a specific number of authorized refills"; P.A. 95-264 divided section into Subsecs., adding new provision
as Subsec. (a) permitting electronically transmitted prescriptions, made technical changes and required pharmacies to
record electronically transmitted prescriptions; Sec. 20-184b transferred to Sec. 20-614 in 1997; P.A. 99-175 made technical
changes and added Subdiv. indicators to Subsec. (b); P.A. 04-107 added Subsec. (d) providing for electronic data intermediaries; P.A. 05-272 amended Subsec. (d)(3) by requiring that regulations adopted by commissioner ensure that procedures
and mechanisms are consistent with provisions and purposes of section and by making technical changes, effective July
13, 2005.